Table of Content


Chapter 1. Global Aquaculture Therapeutics Market Executive Summary
1.1. Global Aquaculture Therapeutics Market Size & Forecast (2022–2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Therapeutics Type
1.3.2. By Target Species
1.3.3. By Administration Route
1.3.4. By Therapeutic Class
1.3.5. By Delivery Form
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Aquaculture Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Producer Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Aquaculture Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Growing Demand for Sustainable Protein Sources
3.1.2. Shift Toward Bio-based Therapeutics (Probiotics, Immunostimulants)
3.1.3. Advances in Diagnostic and Precision Delivery Technologies
3.2. Market Challenges
3.2.1. Fragmented Regulatory Approvals Across Regions
3.2.2. Limited Diagnostic Infrastructure in Developing Markets
3.2.3. Emergence of Antimicrobial Resistance
3.3. Market Opportunities
3.3.1. Development of Species-Specific Formulations
3.3.2. Integration of Digital Health Platforms for Real-Time Monitoring
3.3.3. Expansion of Inland and Offshore Aquaculture Systems
Chapter 4. Global Aquaculture Therapeutics Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Aquaculture Therapeutics Market Size & Forecasts by Therapeutics Type 2022–2032
5.1. Segment Dashboard
5.2. Global Market: Therapeutics Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Antibiotics
5.2.2. Antiparasitics
5.2.3. Antivirals
5.2.4. Antifungals
5.2.5. Immunostimulants
5.2.6. Probiotics
5.2.7. Prebiotics
5.2.8. Other Aquaculture Therapeutics
Chapter 6. Global Aquaculture Therapeutics Market Size & Forecasts by Target Species 2022–2032
6.1. Segment Dashboard
6.2. Global Market: Target Species Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Salmon
6.2.2. Trout
6.2.3. Tilapia
6.2.4. Carp
6.2.5. Catfish
6.2.6. Shrimp
6.2.7. Other Aquatic Species
Chapter 7. Global Aquaculture Therapeutics Market Size & Forecasts by Administration Route 2022–2032
7.1. Segment Dashboard
7.2. Global Market: Administration Route Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. In-feed
7.2.3. Injection
7.2.4. Bath
7.2.5. Topical
Chapter 8. Global Aquaculture Therapeutics Market Size & Forecasts by Therapeutic Class 2022–2032
8.1. Segment Dashboard
8.2. Global Market: Therapeutic Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Bacterial Infections
8.2.2. Parasitic Infections
8.2.3. Viral Infections
8.2.4. Fungal Infections
8.2.5. Immunological Disorders
8.2.6. Nutritional Disorders
8.2.7. Other Therapeutic Classes
Chapter 9. Global Aquaculture Therapeutics Market Size & Forecasts by Delivery Form 2022–2032
9.1. Segment Dashboard
9.2. Global Market: Delivery Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Tablets
9.2.2. Capsules
9.2.3. Powders
9.2.4. Liquids
9.2.5. Injectables
Chapter 10. Global Aquaculture Therapeutics Market Size & Forecasts by Region 2022–2032
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.2. Europe
10.2.1. UK
10.2.2. Germany
10.2.3. France
10.2.4. Spain
10.2.5. Italy
10.2.6. Rest of Europe
10.3. Asia Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia Pacific
10.4. Latin America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Saudi Arabia
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Elanco Animal Health
11.1.2. Zoetis Inc.
11.1.3. Virbac SA
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Elanco Animal Health
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Zoetis Inc.
11.3.3. Virbac SA
11.3.4. Merck Animal Health
11.3.5. Benchmark Holdings plc
11.3.6. Phibro Animal Health Corporation
11.3.7. AquaTactics Fish Health
11.3.8. Dechra Pharmaceuticals PLC
11.3.9. Archer Daniels Midland (ADM)
11.3.10. Bayer Animal Health
11.3.11. Alltech
11.3.12. Skretting
11.3.13. EWOS (Cargill)
11.3.14. Biomin Holding GmbH
11.3.15. Novozymes
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes



List of Figures

List of Figures
FIG 1. Global Aquaculture Therapeutics market research methodology
FIG 2. Global market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global market key trends 2023
FIG 5. Global market growth prospects 2022–2032
FIG 6. Global market Porter’s Five Forces model
FIG 7. Global market PESTEL analysis
FIG 8. Global market value chain analysis
FIG 9. Global market by Therapeutics Type, 2022 & 2032 (USD Billion)
FIG 10. Global market by Target Species, 2022 & 2032 (USD Billion)
FIG 11. Global market by Administration Route, 2022 & 2032 (USD Billion)
FIG 12. Global market by Therapeutic Class, 2022 & 2032 (USD Billion)
FIG 13. Global market by Delivery Form, 2022 & 2032 (USD Billion)
FIG 14. Global market regional snapshot 2022–2032
FIG 15. North America market 2022 & 2032 (USD Billion)
FIG 16. Europe market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific market 2022 & 2032 (USD Billion)
FIG 18. Latin America market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa market 2022 & 2032 (USD Billion)
FIG 20. Global market company market share analysis (2023)

List of Tables

List of Tables
TABLE 1. Global Aquaculture Therapeutics market, report scope
TABLE 2. Global market estimates & forecasts by Region 2022–2032 (USD Billion)
TABLE 3. Global market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 4. Global market estimates & forecasts by Target Species 2022–2032 (USD Billion)
TABLE 5. Global market estimates & forecasts by Administration Route 2022–2032 (USD Billion)
TABLE 6. Global market estimates & forecasts by Therapeutic Class 2022–2032 (USD Billion)
TABLE 7. Global market estimates & forecasts by Delivery Form 2022–2032 (USD Billion)
TABLE 8. U.S. market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 9. U.S. market estimates & forecasts by Target Species 2022–2032 (USD Billion)
TABLE 10. U.S. market estimates & forecasts by Administration Route 2022–2032 (USD Billion)
TABLE 11. U.S. market estimates & forecasts by Therapeutic Class 2022–2032 (USD Billion)
TABLE 12. U.S. market estimates & forecasts by Delivery Form 2022–2032 (USD Billion)
TABLE 13. Canada market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 14. Canada market estimates & forecasts by Target Species 2022–2032 (USD Billion)
TABLE 15. UK market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 16. Germany market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 17. France market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 18. Spain market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 19. Italy market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 20. Rest of Europe market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 21. China market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 22. India market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 23. Japan market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 24. Australia market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 25. South Korea market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 26. Rest of Asia Pacific market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 27. Brazil market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 28. Mexico market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 29. Rest of Latin America market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 30. Saudi Arabia market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 31. South Africa market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)
TABLE 32. Rest of Middle East & Africa market estimates & forecasts by Therapeutics Type 2022–2032 (USD Billion)